The European Medicines Agency is broadening its investigation into a class of popular weight loss and diabetes drugs after patients in Iceland reported thoughts of self-harm and suicide after taking Ozempic and Saxenda. Dr. Celine Gounder. editor-at-large for public health at KFF Health News and a CBS News medical contributor, has more.
